N-(3-((1H-Indol-1-yl)methyl)benzyl)-4-bromo-1H-pyrrole-2-carboxamide

ID: ALA4482946

PubChem CID: 155539848

Max Phase: Preclinical

Molecular Formula: C21H18BrN3O

Molecular Weight: 408.30

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(NCc1cccc(Cn2ccc3ccccc32)c1)c1cc(Br)c[nH]1

Standard InChI:  InChI=1S/C21H18BrN3O/c22-18-11-19(23-13-18)21(26)24-12-15-4-3-5-16(10-15)14-25-9-8-17-6-1-2-7-20(17)25/h1-11,13,23H,12,14H2,(H,24,26)

Standard InChI Key:  WWFMXNRQSXPWTH-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
   32.3726   -1.9810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3714   -2.8047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0836   -3.2137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7974   -2.8042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7945   -1.9774    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0818   -1.5680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.6593   -3.2127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9519   -2.8036    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.8660   -1.9888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0627   -1.8183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1999   -3.1374    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6519   -2.5298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8516   -2.6975    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.5982   -3.4766    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1471   -4.0839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.9454   -3.9130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.5099   -3.2117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2211   -2.8020    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.9335   -3.2095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9348   -4.0308    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.6447   -2.7998    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.3898   -3.1355    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.9396   -2.5261    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.5298   -1.8148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.7269   -1.9848    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.8629   -1.0686    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  2  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 12  1  0
 11  8  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
  4 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 21  2  0
 24 26  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4482946

    ---

Associated Targets(Human)

A-375 (9258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IDO1 Tchem Indoleamine 2,3-dioxygenase (6650 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 408.30Molecular Weight (Monoisotopic): 407.0633AlogP: 4.71#Rotatable Bonds: 5
Polar Surface Area: 49.82Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 4.59CX LogD: 4.59
Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.49Np Likeness Score: -1.36

References

1. Serafini M, Torre E, Aprile S, Grosso ED, Gesù A, Griglio A, Colombo G, Travelli C, Paiella S, Adamo A, Orecchini E, Coletti A, Pallotta MT, Ugel S, Massarotti A, Pirali T, Fallarini S..  (2020)  Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to in Vivo Pharmacodynamic Activity.,  63  (6): [PMID:32150677] [10.1021/acs.jmedchem.9b01809]

Source